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Abstract
Chronic activation of angiotensin II (AngII) type 1 receptor (AT1R), a prototypical G protein-coupled receptor (GPCR) induces
gene regulatory stress which is responsible for phenotypic modulation of target cells. The AT1R-selective drugs reverse the
gene regulatory stress in various cardiovascular diseases. However, the molecular mechanisms are not clear. We speculate
that activation states of AT1R modify the composition of histone isoforms and post-translational modifications (PTM),
thereby alter the structure-function dynamics of chromatin. We combined total histone isolation, FPLC separation, and mass
spectrometry techniques to analyze histone H2A in HEK293 cells with and without AT1R activation. We have identified eight
isoforms: H2AA, H2AG, H2AM, H2AO, H2AQ, Q96QV6, H2AC and H2AL. The isoforms, H2AA, H2AC and H2AQ were
methylated and H2AC was phosphorylated. The relative abundance of specific H2A isoforms and PTMs were further
analyzed in relationship to the activation states of AT1R by immunochemical studies. Within 2 hr, the isoforms, H2AA/O
exchanged with H2AM. The monomethylated H2AC increased rapidly and the phosphorylated H2AC decreased, thus
suggesting that enhanced H2AC methylation is coupled to Ser1p dephosphorylation. We show that H2A125Kme1 promotes
interaction with the heterochromatin associated protein, HP1a. These specific changes in H2A are reversed by treatment
with the AT1R specific inhibitor losartan. Our analysis provides a first step towards an awareness of histone code regulation
by GPCRs.
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Introduction
G protein-coupled receptors (GPCR) are the largest family of
transmembrane molecules that sense environmental signals in
mammalian cells. Accordingly, .50% of the drugs in therapy
target GPCRs, suggesting the physiological and pathophysiological
significance of GPCRs [1,2,3,4]. GPCRs regulate global gene
expression programs leading to diverse integrated responses such
as proliferation, differentiation and apoptosis in cells, but the
mechanisms by which GPCRs modulate the structure-function
relationship of chromatin is unclear. It is well established that
GPCR activation mobilizes transacting factors, such as protein
kinases/phosphatases (e.g., ERK and calcineurin) histone deace-
tylases/acetylases (e.g., HDACs and HATs), and transcription
factors (e.g., NFAT, NK2, MEF2, GATA, Tbx and STAT), which
either ‘induce’ or ‘repress’ gene expression [5,6,7,8,9]. However,
GPCR-modulation of cis-acting epigenetic mechanisms which
could alter the ‘expressibility’ of genes is unknown. The cis-acting
epigenetic regulatory mechanisms could cause long-term changes
in gene expression and would therefore affect sets of genes in
chromatin. The conceptual and operational aspects of this type of
regulation by GPCRs are unexplored.
Chromatin is a complex of DNA with histone and non-histone
proteins. The fundamental unit of the chromatin structure is the
nucleosome, which consists of 146 base pairs of DNA, wrapped
around an octamer of the core histones H2A, H2B, H3, and H4.
Histones constitute 50% of the mass of chromatin and are subject
to a wide range of post-translational modifications (PTM). The
amino-terminal tails of each of the four core histones are targets
for several types of covalent modifications, including acetylation,
methylation, and phosphorylation. In addition, histone isoforms
encoded by distinct genes exist and are regulated in response to
specific signals [10]. GPCRs likely regulate histone isoforms and
PTM to modulate gene expression, but this aspect has not to date
been systematically investigated. We propose that histone
alterations are an index associated with the activity of GPCRs
governing the phenotype of a cell.
The angiotensin type 1 receptor (AT1R) is an ideal model
system for exploring modulation of histone imprints by a GPCR.
Angiotensin II is the primary effector hormone of the renin-
angiotensin system. This hormone regulates the cardiovascular
response through the AT1R [11,12] in diseases such as
hypertension, atherosclerosis, heart-failure, and diabetes
[13,14,15,16,17]. Pathological vascular remodeling and cardiac
PLoS ONE | www.plosone.org 1 September 2010 | Volume 5 | Issue 9 | e12552hypertrophy [18,19,20,21] can be treated with AT1R blocking
(ARB) drugs, thus suggesting that activated AT1R contributes to
changes in the phenotype of cells in vivo. We speculate that a
relative abundance of histone PTM and histone isoforms in
chromatin is a potential index of the activation states of AT1Ri n
cells. Here, we utilize mass spectrometry combined with
biochemical analysis to characterize the relative abundance of
the histone H2A in a human cell line displaying distinct activation
states of the AT1R (Fig. 1). We have documented alteration in the
levels of specific histone H2A modifications, as well as isoforms
when the activation state of the AT1R changes.
Results
General strategy for histone analysis
We compared the histone profiles in HEK293 control cells,
HEK cells that stably express AT1R (HEK-AT1R, 2.8 pmol/mg)
[22], and the agonist-activated HEK-AT1R cells, grown and
processed under identical conditions (Fig. 1). Total histones were
isolated from the purified nuclei by acid extraction as described
earlier [23,24]. Mixed histones were separated by a C18 reverse-
phase FPLC (Fig. 2A) and the fractions were characterized by
SDS-PAGE analysis (Fig. 2B). Fractions of each FPLC peak were
then pooled and analyzed directly by mass spectrometry on an
ion-trap LTQ instrument. The reverse-phase FPLC, using a C8
column, was very efficient in resolving individual histones, yielding
consistent and reproducible elution patterns for the three samples
compared in this study (data not shown).
The FPLC chromatogram showed seven well resolved peaks
(Fig. 2A), which after MS analysis and deconvolution of the
multiple charged ion (8
+ through 25
+) series were identified as
histone proteins H1, H2A, H2B, H3, and H4 (Table 1). The silver
stained gel (Fig. 2B) corroborates these findings. The MS analysis
yielded a range of masses for major histone in each FPLC peak
(Table 1), providing evidence of molecular complexity in each
histone type. In this study, we focused our analysis on the H2A
fractions due to the fact that H2A consistently eluted in two
distinct peaks in all samples. The two H2A peaks differed in the
three samples reproducibly (n=5) when compared to the H2B or
H4 peaks, but displayed identical immuno-reactivity and mobility
on the SDS-PAGE (Fig. 2B and C). The second H2A peak was
broader in HEK-AT1R cells and the peak height increased
substantially when cells were treated with AngII. In addition,
previous reports have suggested potential modulation of H2A gene
expression in mouse models of pressure overload cardiac
hypertrophy [25]. We will embark on the analysis of other histone
peaks following this report.
Complexity of histone H2A
The range of mass observed within H2A peaks led us to analyze
the isoforms and PTM by LC/MS of intact H2A polypeptides.
The molecular masses were determined for both H2A peaks. The
relative abundances were calculated for molecular species that
were consistently observed in the mass spectrum. A comparative
analysis in the three samples provided an index of changes in H2A
as the activation state of AT1R changed (Table 2).
The assignments were based on molecular weights that were
calculated from the mass spectra that matched the predicted
theoretical masses of different H2A subtypes (primarily human)
from known amino acid sequences. Additionally, this assignment
method allowed for post-translational modifications reported in
the NCBI database and has previously been utilized [24]. It should
also be noted here that the putative assignment of PTM in Table 2
is based purely on the consideration that mass increments of 14,
and 28 Da are mono- and di-methylations, a mass difference of
42 Da corresponds to tri-methylation or an acetylation, and an
80 Da difference corresponds to phosphorylation [23,24]. How-
ever, it is important to recognize that two isoforms differing by
such nominal masses cannot be distinguished from post-transla-
tional modified isoforms based solely on mass differences. We did
not, however, encounter isobaric species, which do not resolve.
Hence, the assignment of H2A isoforms and PTM shown in
Table 2 could be made unambiguously.
Histone H2A isoforms
Figure 3 and Table 2 show an overview of the isoforms and
PTM assigned for the two chromatographically distinct FPLC
peaks. The mass spectrum of intact H2A histones allowed a first
assignment of six potential isoforms in the first peak. Deconvoluted
molecular masses at 13899, 14141, 14081, 14047, 14021, and
14008 in the first peak match well with the calculated masses of
histone H2AQ (13899.2 Da), Q96QV6 (14144.3 Da), H2AM
(14083.4 Da), H2AA (14046.3 Da), H2AG (14018.3 Da), and
H2AO (14006.3 Da), respectively. The m/z 1078.3 (z=13)
species, characteristic of H2AO, was well resolved in the
deconvoluted mass spectrum shown in Fig. 3A. This peak was
distinct from the H2AG assigned (m/z 1079.5, z=13) in HEK-
AT1R and HEK-AT1R+AngII samples. Thus, the H2AO isoform
appears to be a legitimate component of the H2A pool in HEK
cells.
Figure 1. Experimental flow chart.
doi:10.1371/journal.pone.0012552.g001
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shown in Fig. 2C, allowed assignment (see Table 2, Fig. 3B) of
three isoforms H2AC (14002.3 Da), H2AL (14016.3 Da), and
H2AM (14083.4 Da). In previous MS and MS/MS analyses in
Jurkat cells, isoforms H2AO, H2AQ, and H2AZ were found in the
first FPLC peak, and isoforms H2AA, H2AC, H2AE, H2AL,
H2AG, and Q96KK5 were found in the second peak, without any
overlap [24]. In our study, the H2AM isoform was present in both
peaks and the composition of isoforms in the two peaks was
different.
H2A histone PTM
Potential PTM of histone H2A were apparent by screening
the masses of the full-length H2A histone for known
Figure 2. Profile of histones purified from HEK nuclear extract. (A) A typical reverse phase FPLC chromatogram of histones used for mass
spectrometry analysis; (B) Silver stained SDS-PAGE of the FPLC fractions; each fraction was confirmed by matching the molecular weight in mass spec
analysis; (C) comparision of FPLC peaks of histone H2A in the three experimental conditions; inset depicts western blot verifying both FPLC peaks as
H2A.
doi:10.1371/journal.pone.0012552.g002
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deconvoluted molecular mass at 14060 Da matched the 1-me
form of H2AA (14046+13.7 Da). This form was observed in all
samples (Table 2). The experimentally derived mass of
13945 Da did not directly match any human H2A isoforms
in our list. Each sample showed this form. Calculated
molecular weights from this ion gave the closest match to a
possible acetylation (or tri-methylation) on the H2AQ isoform
(MW: 13899+45.8 Da).
In the H2A (second peak), molecular masses 14014, 14029 and
14048 Da matched mono-, di-, and tri-methylated (or acetylated)
forms of the histone H2AC (14002 Da) isoform (Table 2), which
was consistently observed in all samples (Fig. 3B). Finally, mass
14086 Da matched the mono-phosphorylated molecular mass of
H2AC variant (14002+83.7 Da). The m/z 1085.4 (z=+13) ion
form was present in the mass spectra of AT1R expressing samples.
A deconvoluted mass of this form corresponds to a PO4+O
molecular species. The +16 modification (O) are commonly
assigned to oxidation that can occur on both Met and Trp residues
in proteins. Since we do not currently have sufficient information
to assign this ion, the identity or significance of this species is not
further characterized at this time.
Table 1. Identification of histones in the FPLC peaks.
Number FPLC-Peak (ml) Mass range by mass spec Histone assignment Observed molecular weight (KDa)
1 45.42 22620-21805 H1 32–33
2 51.75 13815-13774 H2B 15
3 52.17 14046-13930 H2A-1 14
4 53.31 14046-13930 H2A-2 14
5 54.32 11742-11307 H4 11
6 58.51 15410-15187 H3-1 17
7 60.26 15645-15358 H3-2 17
Column one is retention ml for each peak. Column two is experimental mass range in each peak, column three shows the assignment of histone, and column four is
relative molecular weight (KDa) based on mobility in SDS-PAGE shown in Fig. 2B.
doi:10.1371/journal.pone.0012552.t001
Table 2. Isoform and PTM combinations observed in the H2A peaks from HEK cell lines.
Mass (Da) Relative Abundance (%)
Assignment
13
+ Charge state
(m/z) Deconvoluted Calculated* Dm (Da) HEK HEK-AT1R HEK-AT1R +AngII
First Peak
H2AA 1081.4 14047 14046.3 0.7 3 2 5
H2AA+1me 1083.4 10460 14046.3 13.7 2 5 3
H2AG 1079.5 14021 14018.3 2.7 21 22 15
H2AM 1084.3 14081 14083.4 22.4 0 2 2
H2AO 1078.3 14008 14006.3 1.7 21 0 0
H2AQ 1071.3 13899 13899.2 20.2 8 4 12
H2AQ+Ac/(3me) 1074.6 13945 13899.2 45.8 2 1 3
Q96QV6 1087.2 14141 14144.3 23.3 1 4 4
Second Peak
H2AC 1078.0 14002 14002.3 20.3 21 30 22
H2AC+1me 1079.2 14014 14002.3 11.7 6 8 9
H2AC+1P 1084.1 14086 14002.3 83.7 4 2 2
H2AC+2me 1080.2 14029 14002.3 26.7 4 4 5
H2AC+3me/(Ac) 1081.1 14047 14002.3 44.7 6 10 11
H2AL 1091.9 14022 14016.3 5.7 1 1 2
H2AM 1084.3 14084 14083.4 0.6 0 8 6
Isoforms and PTMs observed in the H2A peaks from HEK cell lines. First and second histone H2A FPLC peaks were subjected to mass spectrometry analysis. Each row in
the table represents a discrete H2A polypeptide species assigned based on the mass. Assignment was done by comparing measured masses to calculated molecular
weights of histone isoforms based on primary sequences taken from the NCBI database and allowing for modifications. Column one is the assignment of H2A isoforms
and modifications, column two contains m/z for each isoform and modification at 13+ charge state, columns three and four contain deconvoluted and calculated mass
(from NCBI database) respectively; Dm, difference in mass between calculated and deconvoluted mass (Da). The last three columns contain the relative abundance (%)
of the isoforms and their post translational modifications (p,0.05 in 3–5 determinations). The relative abundance is taken directly from Mass Scans.
*Mass values based on NCBI database.
doi:10.1371/journal.pone.0012552.t002
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The relative heights of the two H2A peaks differed reproducibly
in the three samples when compared to the H2B peak (Fig. 2C).
The second H2A peak was broader in HEK-AT1R cells and the
peak height increased substantially when treated with AngII. The
changes observed in the FPLC profile were further substantiated
by the mass spectrometry analysis (Table 2). The composition of
isoforms in the H2A peak 1 (six isoforms) and peak 2 (three
isoforms) changed in the HEK-AT1R and the AngII activated
HEK-AT1R cells when compared to HEK cells. These samples
contained substantially higher levels of isoforms H2AM and
Q96V6, and completely lacked H2AO, a major isoform in HEK
cells. In addition, the relative abundance of different isoforms was
altered (see Table 2).
Dynamic changes in the post-translational modification of H2A
histones are evident in our experiment(s). Nearly 16% of the
H2AC variant was methylated in HEK control cells. In HEK-
AT1R, this fraction increased slightly (21%), but the di- and tri-
methyl forms significantly increased. This suggests either modifi-
cation at additional sites on H2AC or further modification of
mono-methylated residues. The total methyl-H2AC fraction
increased to 25% upon AngII activation. Methyl-H2AA and
acetyl-H2AQ (or me3) isoforms increased in the AngII activated
HEK-AT1R cells. Together, these results indicate increased H2A
Figure 3. Mass spectrum of intact histone H2A from FPLC peaks showing resolution of isoforms and PTM. (A) The figure shows the
spectrum expanded at 13+ charged state for all three (HEK, HEK-AT1R and HEK-AT1R+AngII) experimental conditions. The masses of the intact histone
components were determined after deconvolution of the multiple charge ion series (not shown). This peak fraction contains multiple isoforms of
H2A. This spectrum shows that H2A isoforms H2AG/H2AO (1079.5 m/z) did not appear in HEK-AT1R+AngII treated condition; the appearance of
H2AM can also be seen in this peak (See Table 2). (B) Molecular masses of FPLC peak 2: intact histones from H2A peak determined after
deconvolution of the multiply charged ion series, expanded at 13+ charged state for all three experimental conditions. In this peak fraction the major
isoform is H2AC (1078 m/z) and its modifications. In this spectrum, phosphorylation of H2AC is reduced (H2AC+1P) (1084.1 m/z) in HEK-AT1R and
HEK-AT1R+AngII conditions and an increase of H2AC monomethylation can be seen (See Table 2).
doi:10.1371/journal.pone.0012552.g003
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phosphorylated H2AC (4%) present in HEK cells is substantially
decreased, indicating H2AC dephosphorylation in the HEK-
AT1R and AngII-activated HEK-AT1R cells. Taken together
these findings suggest that the abundance of H2A PTM is altered
significantly in the presence of AT1R. The methylation and
dephosphorylation of the H2AC isoform could be novel AT1R-
specific signaling events.
Immunochemical analysis validates H2A isoforms and
PTM
To independently support the mass spectrometry results, we
immunoblotted nuclear proteins using commercially available
antibodies for H2A isoforms and PTM (see Fig. 4). The H2AA/
H2AO isoform-specific antibody detected the H2A band in HEK
cells, which decreased in HEK-AT1R and AngII activated HEK-
AT1R cells. The H2AA/H2AO isoform-specific antibody signal
substantiates MS data shown in Table 2 , (i.e., the absence of
H2AO and the presence of a smaller amount of H2AA in the
AT1R-expressing cells).
H2AM was detected by the H2AM/P25 hydroxyprolyl isoform-
specific antibody in the HEK-AT1R and AngII activated HEK-
AT1R samples. The H2A125Kme1 modification was detected
both in HEK-AT1R and AngII activated HEK-AT1R cells at
higher levels than in the control HEK cells. The H2A1Sp antibody
gave a strong signal in the control cells, as predicted from the mass
spectrometry data. This signal decreased substantially upon AngII
activation in the HEK-AT1R cells.
We could not independently confirm the presence of methylated
H2AA or acetylated H2AQ isofoms due to the fact that there are
no commercially available antibodies specific for these modifica-
tions. Similarly, the immunochemical evidence for presence and
exchange of isoforms H2AG, H2AQ, H2AC, and H2AL could not
be obtained due to lack of commercially available antibodies.
Thus, immunoblot analysis using four different H2A-directed
antibodies validated the MS data which suggested that AT1R-
induces changes in composition of histone H2A-isoforms and
PTM. These four antibodies were utilized to further confirm the
selectivity of AT1R in causing the changes in the composition of
histone H2A-isoforms and PTM.
Regulation of H2A isoforms and PTMs in response to
endogenous AT1R activation
In the HEK293 cells the H2A histone changes in response to
AngII treatment was variable (i.e., H2AM/P25hydroxyl signal in
Fig. 4A), presumably due to low levels of AT1R as reported
previously (http://www.tumor-gene.org/cgi-bin/GPCR/by_cell_
line.cgi). To examine whether AT1R activation in untransfected
cells regulates H2A isoforms and PTMs, we have used H9C2, HL-
1 and HASMC muscle cell lines. Nuclear extracts from AngII
activated cells were used for immunoblot analysis of H2A isoforms
and PTMs (see Fig. 4B). The H2AA/O isoform decreased in all
three cell types; the H2AM/P25 hydroxyprolyl was increased. The
level of H2A125Kme1 modification was higher and the H2A1Sp
decreased substantially in all three cell types (see Fig. 4B). Losartan
blocked these AngII-induced changes in all three cell lines (data
not shown).
The activation states of AT1R alter the dynamics of
histone H2A isoforms
The states of AT1R induced by AngII and losartan dynamically
regulate isoforms H2AA/O and H2AM. AngII-stimulated an
increase of H2AM and a disappearance of the H2AA/O isoform
in 2–4 hr time-kinetics (see Fig. 5A). Treatment of HEK-AT1R
cells with losartan showed decrease of H2AM by 4 hr (Fig. 5B);
whereas, the H2AA/O isoforms showed an increase as anticipat-
ed. Losartan is an inverse agonist of AT1R. Hence, the result of
the losartan treatment confirms direct involvement of AT1R in the
exchange of these two H2A isoforms.
Ligand-dependent alteration of H2A-PTMs and
association with functional molecules
The dynamic regulation of H2A-PTM is rapid when compared
to the exchange of isoforms. Phosphorylation of H2AC1Ser
increased transiently up to 5 min after AngII treatment, and was
followed by a decrease to a steady-state level in HEK-AT1R cells
(Fig. 6A). When HEK-AT1R cells were treated with losartan, this
process displayed an opposite trend, reaching a higher steady-state
level of H2AC1Ser phosphorylation than untreated HEK-AT1R
(Fig. 6B). H2A methylation, which was monitored by an
H2A125Kme1 antibody, increased upon AngII treatment
(Fig. 6A) and was inhibited by losartan treatment (Fig. 6B).
To decipher possible functions mediated by these two PTMs, we
examined interacting proteins. H2A1Sp was associated with a
catalytic subunit of protein phosphatase 2A. We then measured the
phosphatase activity associated with the H2A1Sp immunoprecipitate.
Upon AT1R activation the associated phosphatase activity decreased,
which correlates with the decrease of H2A1Sp. When AT1R
signaling was blocked by treatment with losartan, the phosphatase
activity associated with H2A increased. The histone methyl
transferase (HMTase) activity associated with H2A increased upon
AT1R activation and the association decreased when the AT1R
signaling was blocked with losartan. Together, these results indicated
that H2A1Sp and H2A125Kme1 modifications promote the
association of phosphatase and HMTase with the chromatin.
We immunoprecipitated H2A and probed for H2A125Kme1
and the associated heterochromatin marker protein HP1a in HEK-
AT1R and vascular smooth muscle cells. As shown in Fig. 6C, when
H2A125Kme1 was present, the association of HP1a was signifi-
cantly higher. When treated with losartan, the association with
HP1a is reduced, thus suggesting that the HP1a interaction is
facilitated by the H2A125Kme1 modification that is induced by
AT1R activation. In previous studies Hirota et al., 2005, found that
the phosphorylation of histone H3 at Ser-10 negatively regulated
the binding of HP1a to the adjacent methylated Lys-9 of histone
H3. Based on their study of histone H3 modifications, these authors
proposed the binary switch hypothesis [26]. We propose that
dephosphorylation of the N-terminal H2A1Sp may induce
H2A125Kme1 modification at the C-terminus. This modification
when induced upon AT1R activation promotes hetrochronatin
formation, consequently silencing gene transcription (Fig. 6D). The
changes in histone H2A-PTMs when induced upon AT1R
activation are functionally significant in altering the expression of
genes. It is of great interest to note that pharmacological inhibition
of AT1R produces a change in chromatin histone composition with
functional significance.
Discussion
In this study we present evidence of changes in histones in
HEK293 cells that occur upon de novo expression of AT1R as well
as ligand activation of AT1R. These AT1R-dependent changes are
reversible upon inhibition of AT1R signaling by losartan.
Alteration of chromatin structure in response to change in the
activation-state of AT1R or any other GPCR is not documented.
Modulation of histones by GPCR is most likely a cis-acting
epigenetic chromatin regulatory mechanism. The H2A isoforms
AT1R and Nucleosome Remodeling
PLoS ONE | www.plosone.org 6 September 2010 | Volume 5 | Issue 9 | e12552Figure 4. Immunochemical confirmation of isoforms and PTM of histone H2A. (A) Western blot analysis of nuclear extracts from HEK and
HEK-AT1R cells treated with 1mM AngII for 1 hr using specified antibodies: H2AA/H2AO; H2A125Kme1; H2AM/H2A 25P hydroxyl; H4/H2A1Sp. The
signal from H2AM/H2AP25hydroxyl antibody is indicative of H2AM, because we did not find hydroxyl-Pro in our MS analysis. The Ser-1p antibody
signal is H2A-specific since we excluded H4 in the samples. Histone H3 Western blot was used as a loading control. (B) Western blot analysis of
nuclear extracts from H9C2, HL-1 and HASMC cell lines treated with 1mM AngII for 5 hr using specified antibodies. Actin Western blot was used as a
loading control. Band intensity values were obtained in three independent experiments. The right hand panels in 4B, shows mean 6 SEM values for
change compared to sample without AngII treatment.
doi:10.1371/journal.pone.0012552.g004
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chromatin which is critical for the modulation of global gene
expression. Finding a link between AT1R activation/inhibition
and histone complexity in chromatin is imperative for a better
understanding of molecular mechanisms of phenotypic modula-
tion by AngII in various cell types. Conversely, reversal of AT1R-
induced histone changes in cardiac, vascular and renal cells may
be an essential but uncharted mechanism during therapeutic
intervention with AT1R blockers. Therefore, a complete descrip-
tion of specific chromatin changes induced by AT1R is desirable.
However, because of the enormity of changes hidden in the profile
of each of the histones (Table 1), we restricted our study to H2A
histones. Our reasons for selecting H2A are: (i) limited information
on isoforms and PTM for H2A relative to core histones H3 and
H4; and (ii) a previous study, suggesting that the H2AZ isoform is
differentially regulated during pressure-induced cardiac hypertro-
phy [25]. Our current study is a novel and significant effort
towards our long-term goal to pursue comprehensive analyses of
histone H2A isoforms at the protein level in health and disease.
A key question we explored in this study is the influence of the de
novo expression of AT1R on the composition of core nucleosome
componentsinHEK293cells.Weexaminedchangesinnucleosome
composition incells expressing endogenouslevelsofAT1R (Fig. 4B).
The FPLC purification resolved the histones H1, H2A, H2B, H3,
and H4 into individual peaks (Fig. 1) and enabled MS analysis of
intact histones to document inherent molecular heterogeneity
(Table 1). Each H2A peak contained a mixture of several isoforms
(Fig. 2, Table 2). The isoforms H2AA, H2AG, H2AM, H2AO,
H2AQ, and Q96QV6 were identified in the first FPLC peak;
whereas, H2AC, H2AL, and H2AM, were found in the second
FPLC peak. These isoforms are products of various genes that
encode slightly different primary sequences shown in Fig. 7 [26,27].
The human genome encodes four replacement H2A histones;
H2AZ, macroH2A, H2A-Bbd, and H2AX. We did not find
evidenceofreplacementhistonesinthe FPLCpeaksanalyzedinany
of the samples [28,29]. Histone H2AZ, reported to be important in
cardiachypertrophy[28,29],was not detected inanyofthe samples,
suggesting that H2AZ is not responsive to AngII.
Although the possibility of not recovering all minor isoforms
and rare modifications cannot be ruled out in our analysis, the MS
data already suggests that the AT1R activation/inhibition causes
fluctuation of several interesting and perhaps unique isoforms (i.e.,
Q96QV6, H2Q, H2AAme1, H2AQAc and H2AL) and PTM
(Table 2), which must alter the composition of the nucleosome.
The exchange of H2AA/O and H2AM isoforms is clearly an
AT1R-specific signaling event since AngII treatment increased
H2AM and decreased H2AA/O. Losartan treatment increased
H2AA/O, as we anticipated from the inhibition of the constitutive
activity of AT1R by losartan (Figs. 4 and 5B). The PTMs of H2AC
isoform assessed by mass spectrum (Fig. 3A and B) and
biochemical analysis (Figs. 4 and 6) also indicates AT1R-specific
modulation. Unavailability of reliable isoform-specific antibodies
limited extensive analysis of all isoforms in this study. The AT1R-
induced H2AA/O exchange with H2AM documented here is
suggestive of a genome-wide pattern of exchange. AngII-induced
histone changes in cardiac and smooth muscle cell lines (Fig. 4B)
demonstrates that the histone changes may play a role in vivo in
directly regulating the long-term response of genes or induce
changes in phenotype of these cells. For instance, minor histone
isoforms are known to be placed at strategic locations in the
genome, such as gene regulatory regions [30,31,32]. This would
provide a mechanism for regulating genes through variegation of
chromatin domains and alter higher order chromatin structure.
The differences in the sequence of histone isoforms affects
chromatin function by providing binding sites to other histone
isoforms, modifying enzymes or transcription factors and thus may
alter nucleosome stability [26].
Reciprocal modulation of H2AC PTM, 1Serp and 125Kme1,
by AT1R activation/inhibition is an important discovery. Of all
H2A isoforms, H2AC is unique in containing a threonine at
position 16 and alanine at position 40 (see Fig. 6). These
substitutions together could produce a relatively less compact
nucleosome core. As a result, the H2AC1Ser at the N-terminus or
H2AC125K near the C-terminus may become more sensitive to
dephosphorylation and methylation, respectively, than other H2A
isoforms upon AT1R activation. Previous studies indicate that
Figure 5. Time course analysis of ligand-dependent exchange of H2AA/O and H2AM isoforms. The H2A isoforms were immunoblotted
using isoforms-specific antibodies, H2AA/O and H2AM/H2A 25P hydroxyl after treatment of HEK-AT1R with AngII (1mM) or losartan (1mM). Each data
point shown represents mean 6 SEM of 3–5 independent experiments. Significance values shown are for comparison between 0 and 4 hr time
points, obtained by one-way ANOVA followed by unpaired Student t-test. P-values less than 0.05 are considered statistically significant.
doi:10.1371/journal.pone.0012552.g005
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by GAL4 and MSK1 [35] and mitotic chromosome condensation
[36]. Several PTM described in the literature for H2A histones
[24,37,38] were not found in our model, which is a AT1R over
expressing human cell line. For example, human histone H2A
modifications already reported include acetylation on Lys-5 and
Lys-9, ubiquitination on Lys-119 in the carboxyl-terminal region
[39,40], and phosphorylation of H2AX Ser-139. H2A125Kme1
has also been shown in cancer cells [41,42].
In general, core histone PTMs regulate one another and can
influence the occurrence of subsequent modifications either on the
same or an adjacent nucleosome. Therefore, H2AC1Sp dephos-
phorylation coupled to methylation of H2AC125K affected by the
activation/inhibition of AT1R is consistent with the idea of a
simple redundant ‘histone code’ as seen in several other regulatory
systems [43,44,45,46]. The histone code is deciphered by binding
of effectors that further modify the ‘histone code’ and modulate
specific gene activity [43,44,45]. Therefore, the association of
PP2A and HMTase activities with H2AC regulated by AT1R
activation/inhibition is significant. Dephosphorylation of
H2AC1Sp could open the C-terminal tail domain of H2AC for
association with HMTase leading to methylation of H2AC125K
which facilitates interaction with the heterochromatin protein
HP1a. This interaction is likely to be involved in directing the
HP1a-bound nucleosomes to heterochromatic regions that are
known to be enriched in unphosphorylated H2A. Dephosphory-
lation of nucleosome core histones could promote methyl-Lys-
bound HP1a to self-associate within a region of chromatin
[47,48,49]. A recent study [50] has shown that the HP1a can also
associate with other HP1 isoforms which in turn can bind to the
linker histone H1b. Therefore, the modification status of histone
H2AC could change the balance between transcriptionally active
Figure 6. Time course analysis of ligand-dependent change of H2A-PTMs. Dephosphorylation of H2A detected by H2A1Sp antibody and
monomethylation of H2A detected by the H2A125Kme1 antibody. (A) Time course of H2A1Sp and H2A125Kme1 signal modulation in HEK-AT1R
treated with AngII (1mM); (B) HEK-AT1R cells treated with losartan (1mM). (C) H2A125Kme1 interaction with HP1a in HEK-AT1R and HASMC treated
with AngII (1mM) or losartan (1mM) for 1 hr. Nuclear extracts of various samples were immunoprecipitated using pan-H2A antibody followed by
immunoblotting for H2A125Kme1 and HP1a in the immunoprecipitate, (D) Schematic representation of functional consequences of two H2A-PTMs
affected by activation states of the AT1R.
doi:10.1371/journal.pone.0012552.g006
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losartan would also influence the chromatin structure because it
would lead to a decreased affinity for HP1a. Thus, the model
shown in Fig. 6D provides a mechanism by which AT1R signaling
leads to HP1a mediated regulation of chromatin activity.
Exchange of H2AA/O isoforms with H2AM (Fig. 5) appears
to be a slower process than PTM changes. The consequence of
isoform exchange may last longer and changing PTM may be
important to moderate acute response. Altering chromatin
response to AT1R in vivo may utilize both mechanisms, but the
emphasis on altering PTM or isoforms may differ under chronic
and acute conditions. Long-term treatment with AT1Rb l o c k e r s
may reset gene expression by altering the composition of
isoforms and PTM. Histone changes of promoter-proximal
nucleosome provide the syntax (or context) that correlates with
transcriptional activity in vivo. The ability of RNA polymerase II
to cross the first nucleosome it encounters is a major, and
general, control point for gene expression. Nucleosomes
positioned after the TATA box form a strong blockade to
RNA polymerase and the exchange of H2A/H2B dimers is a
critical step that reduces the barrier for nucleosome traversal of
RNA polymerase at transcribed genes [51]. How AT1Rm i g h t
regulate this process through its influence on H2A would be
important to discern. Hence, considering AT1R-induced
chromatin changes as part of the mechanism of global gene
expression is critical. The study of AT1R-sensitive PTM and
isoforms controlling expression of specific genes in cardiac
hypertrophy and heart failure are of great importance.
Figure 7. Sequence comparison of human H2A isoforms. The vertical boxes highlight the 16
th and 40
th amino acid residue position in the
eight H2A variant sequences. The horizontal box shows the unique feature of H2AC, which has a threonine at the 16
th position, but an alanine at the
40
th position. We speculate that interactions of Thr-16 and Ala-40 in the H2AC variant may play a role in AngII-responsive Ser-1 dephosphorylation
and Lys-125 methylation, the residues are shown in black circles.
doi:10.1371/journal.pone.0012552.g007
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responsive to the functional states of the AT1R, a GPCR. AT1R
initiated swapping of histone isoforms and modification of histones
in the nucleosome is a regulatory cryptogram for deciphering the
encoded genomic information in the context of regulating the gene
expression. We suggest that histone replacement and modifications
associated with activation states of GPCRs may play an important
role in the progression of disease. GPCRs activate rapid
transmission of signals in mediating acute and chronic adaptive
responses of cells to a host of ligands. GPCRs also amplify cellular
response by activating transcription factors and components of the
transcription machinery. However, the dynamic regulation of the
structure of chromatin has largely been neglected as a relevant
target of GPCR signaling pathways. In essence our work eludes to
the regulation of the histone code by a GPCR [52], which accounts
for many chromatin functions, including transcriptional regulation
through cis-acting (local and global chromatin compaction), as well
as transacting (recruitment of transcriptional activators and
inhibitors) mechanisms of epigenetics [53]. GPCRs are the known
targets for .50% of approved drugs and intended targets of novel
drug development efforts [2,4,12,54,55,56]. Drug therapy targeting
GPCRs may reverse the changes in the histone code. The classical
antagonists and inverse agonists may exert significantly different
influences on the reversal of the histone code (see Fig. 8).
In summary, we presented the analysisof H2A histone isoforms and
PTM in HEK cell lines each tuned to a distinct activation state of a
GPCR, the AT1R for the peptide hormone AngII. This is the first
reported analysis of H2A histone remodeling that occurs in chromatin
upon expression and hormone-stimulation of a GPCR. Overlapping
and distinctive changes seen in HEK-AT1Ra n dH E K - A T 1R+AngII
cells might indicate a scenario one might anticipate in chronic and
acute influence of AT1R. The histone index may influence the
physiological state of cells modifying cellular phenotypes in the process
of disease, as well as provide new targets for drug therapy.
Materials and Methods
Preparation of nuclei from cell lines and extraction of
histones
Human embryonic kidney cell line (HEK293) purchased from
American Type Culture Collection (ATCC, Manassas, VA).
(HEK293) stably harboring pCDNA3 empty vector, HEK293
harboring pCDNA-AT1R vector stably expressing 2.8 pmol/mg
AT1R (HEK-AT1R)[22],HEK-AT1R line treatedwith1mM AngII
for 1 hr (HEK-AT1R+AngII) were cultured in DMEM medium
containing 10% FCS, 100 IU penicillin/streptomycin, and 600mg/
ml G418. The H9C2 cell line originally derived from embryonic rat
heart was purchased from ATCC, (catalog # CRL-1446). HL-1
cardiac myocytes were cultured in Claycomb medium containing
10%FCS [57] and serum starved beforetreatment with1mM AngII
for 5 hr. The human aortic smooth muscle cells (HASMC) were a
gift (A. Majors) [58]. The HASMC was cultured in DMEM
medium containing 10% FCS, 100 IU penicillin/streptomycin, and
serum starved cell lines treated with 1mM AngII for 5 hr. Cells were
washed twice with PBS, the cell pellet was suspended in lysis buffer
(250 mM sucrose, 50 mM Tris-HCl, pH 7.5, 25 mM KCl, 5 mM
MgCl2, 1% protease inhibitor (Sigma), 50 mM NaHSO3,4 5m M
sodium butyrate, 10 mM b-mercaptoethanol, 0.2% Triton X-100)
and centrifuged at 8006 g for 15 min to obtain nuclei. For
preparing histones, nuclei were extracted in 6 volumes of 0.2 M
Figure 8. Model for modulation of H2A histone index in AT1R signaling. The bar graph summarizes the H2A index deduced in this study.
The scheme shows reversible changes in the histone code influenced by activation states of the GPCR, AT1R.
doi:10.1371/journal.pone.0012552.g008
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supernatants were precipitated with trichloroacetic acid (25% final
concentration). The pellet was washed with 1% HCl in acetone,
followed by 100% acetone, and subsequently dissolved in b-
mercaptoethanol (0.1%) in water. This protocol is modified from
that described in references [23,24].
FPLC separation of histones
Bulk histones obtained by acid extraction of HEK cells were
fractionated on a C8 column (22064.6 mm Aquapore RP-300,
Perkin-Elmer) using a linear ascending gradient of 0–100% solvent
B (solvent A, 5% acetonitrile, 0.1% TFA; solvent B, 90%
acetonitrile, 0.1% TFA) for .75 min at 1.0 mL/min on an
AKTA FPLC system (Amersam Bioscience). The elution profile
was monitored at 214 nm, and 0.5 mL fractions were collected.
Fractions from each peak were pooled, dried under a vacuum, and
stored at 280uC. Prior to MS analysis an aliquot from each
fraction was resolved on a 4–12% SDS-PAGE gel to assess the
purity of the fractionated histones [24].
Mass spectrometry
Preparative FPLC fractions containing individual histones, as
detected by UV and MS chromatograms, were pooled. Bradford
assay gave a tentative concentration of <0.02mg/mL for fraction 2
and <0.08mg/mL for fraction 3. For MS analysis, <50mL of each
sample was dried in a SpeedVac and then redesolved in <5mLo f
1.0% aqueous formic acid.
The LC-MS system is a Finnigan LTQ-linear ion trap mass
spectrometer system equipped with a nanoelectrospray source and
interfaced to a self-packed 9 cm675mm inner-diameter Phenom-
enex JupiterC18reversed-phasecapillarychromatographycolumn.
The sample (0.5 to 2mL) was injected, based on the approximate
concentration of protein as assessed by the chromatographic peak
heights. Proteins were then eluted from the column by an
acetonitrile/0.1% formic acid gradient (0–100%) at a flow rate of
0.2mL/min. The nanoelectrospray ion source was operated at a
spray voltage of 2.5 kV and capillary temperature of 160uC. Profile
mass scans were acquired in the positive ion mode within the range
of 300–1800 Da. The mass accuracy of the instrument for intact
proteins was set to be 100 ppm in the analysis. The molecular
masses of the histones were determined by deconvoluting the
multiple chargedionseries, which typically ranfrom 8
+ through 25
+
(Bioworks Software, Thermo Finnigan). Assignment of the correct
histone isoforms was performed by comparing the measured masses
to calculated masses of histone sequences taken from the NCBI
database (primarily human) (see Table 2).
Immunoblotting and immunoprecipitation
Total nuclear extract and immunoprecipitated (with anti-H2A
and anti-H2A1Sp) samples were separated by gel electrophoresis
on an 18% SDS–PAGE gel before being transferred to the PVDF
membrane (BioRad) as previously described [59]. Blots were
probed with a 1:5000 dilution of anti-H2A polyclonal antisera
(Upstate); 1:1000 dilution of anti-H2AA/H2AO (Novus Biologi-
cals); and a 1:250 dilution of anti-H2A hydroxyl P26/H2AM
(Abcam) in 5% non-fat milk, PBS, 0.1% Tween-20, followed by
incubation with a horseradish peroxidase conjugated goat anti-
rabbit, 1:250 dilution of anti-H2A mono-methyl K125 (Abcam)
anti-mouse in 5% non-fat milk, PBS, 0.1% Tween-20, followed by
incubation with anti-mouse secondary antibody, 1:5000 dilution of
anti-H2A/H4 phospho Ser1 (Active Motif) anti-rabbit in 5% non-
fat milk, PBS, 0.1% Tween-20, followed by incubation with anti-
mouse secondary antibody. Detection was performed using ECL
chemiluminescence substrate (Amersham Pharmacia).
Histone methyltransferase assay
We performed the assays as described earlier [59] using an HMT
Assay Reagent Kit (Upstate). H2A-associated methyltransferase assays
were completed by incubating 50mg of histone H2A immunoprecip-
itate with S-adenosyl-[methyl-
3H]-l-methionine (25mCi/mL) and/or
S-adenosylmethionine (New England BioLabs) as the methyl donor.
Reactions were performed at 30uC for 80 min. To stop the reaction,
acetic acid was added to a final concentration of 10% (v/v).
Phosphatase activity assay
PP2A activity was determined using a PP2A Immunoprecipi-
tation Phosphatase Assay Kit (Upstate). After the indicated
treatments, cells were washed twice in cold phosphate-buffered
saline. Nuclear lysates containing 200mg of protein were incubated
with 4mg of anti- H2A1Sp and 40mL of protein A-agarose slurry
for 2 hr at 4uC with constant rocking. The immunoprecipitates
were washed three times in tris-buffered saline one time with Ser/
Thr phosphatase assay buffer (50 mm Tris-HCl, pH 7.0, 100mm
CaCl2), and resuspended in 20mL of the assay buffer. The reaction
was initiated by the addition of 60mL of phosphopeptide substrate
(750mm) (KRpTIRR). Following incubation for 10 min at 30uCi n
a shaking incubator, the reaction mixture was briefly centrifuged
and the supernatant transferred to a 96-well microtiter plate. The
reaction was terminated by the addition of malachite green
phosphate detection solution for 10–15 min at room temperature,
and free phosphate was quantified by measuring the absorbance of
the mixture at 650 nm using a microplate reader.
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